Cargando…
SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge
Coronavirus Disease 2019 (COVID-19), caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has highlighted the need for the rapid generation of efficient vaccines for emerging disease. Virus-like particles, VLPs, are an established vaccine technology that produces vi...
Autores principales: | Sullivan, Edward, Sung, Po-Yu, Wu, Weining, Berry, Neil, Kempster, Sarah, Ferguson, Deborah, Almond, Neil, Jones, Ian M., Roy, Polly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143203/ https://www.ncbi.nlm.nih.gov/pubmed/35632656 http://dx.doi.org/10.3390/v14050914 |
Ejemplares similares
-
Immunogenicity and Antigenicity of Rabbit Hepatitis E Virus-Like Particles Produced by Recombinant Baculoviruses
por: Bai, Huimin, et al.
Publicado: (2021) -
Use of Bacterial Artificial Chromosomes in Baculovirus Research and Recombinant Protein Expression: Current Trends and Future Perspectives
por: Roy, Polly, et al.
Publicado: (2012) -
Generating a host range-expanded recombinant baculovirus
por: Wu, Chunfeng, et al.
Publicado: (2016) -
Immunogenicity and protective efficacy of human metapneumovirus virus-like particles produced by a recombinant baculovirus in mice
por: Ma, Fenlian, et al.
Publicado: (2023) -
Characterization of self-assembled virus-like particles of rat hepatitis E virus generated by recombinant baculoviruses
por: Li, Tian-Cheng, et al.
Publicado: (2011)